Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · IEX Real-Time Price · USD
229.89
-2.80 (-1.20%)
May 2, 2024, 4:00 PM EDT - Market closed
CRL Employees
Charles River Laboratories International had 21,800 employees on December 31, 2023. The number of employees increased by 400 or 1.87% compared to the previous year.
Employees
21,800
Change (1Y)
400
Growth (1Y)
1.87%
Revenue / Employee
$189,422
Profits / Employee
$21,772
Market Cap
11.80B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21,800 | 400 | 1.87% |
Dec 31, 2022 | 21,400 | 1,400 | 7.00% |
Dec 25, 2021 | 20,000 | 1,600 | 8.70% |
Dec 26, 2020 | 18,400 | 1,300 | 7.60% |
Dec 28, 2019 | 17,100 | 2,400 | 16.33% |
Dec 29, 2018 | 14,700 | 2,900 | 24.58% |
Dec 30, 2017 | 11,800 | 800 | 7.27% |
Dec 31, 2016 | 11,000 | 2,400 | 27.91% |
Dec 26, 2015 | 8,600 | 700 | 8.86% |
Dec 27, 2014 | 7,900 | 200 | 2.60% |
Dec 28, 2013 | 7,700 | 500 | 6.94% |
Dec 29, 2012 | 7,200 | 100 | 1.41% |
Dec 31, 2011 | 7,100 | -400 | -5.33% |
Dec 25, 2010 | 7,500 | -500 | -6.25% |
Dec 26, 2009 | 8,000 | -1,000 | -11.11% |
Dec 27, 2008 | 9,000 | 500 | 5.88% |
Dec 29, 2007 | 8,500 | 500 | 6.25% |
Dec 30, 2006 | 8,000 | -400 | -4.76% |
Dec 31, 2005 | 8,400 | 400 | 5.00% |
Dec 25, 2004 | 8,000 | 3,500 | 77.78% |
Dec 27, 2003 | 4,500 | -500 | -10.00% |
Dec 28, 2002 | 5,000 | 1,000 | 25.00% |
Dec 29, 2001 | 4,000 | 500 | 14.29% |
Dec 30, 2000 | 3,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Tenet Healthcare | 106,500 |
DaVita | 70,000 |
Dr. Reddy's Laboratories | 25,863 |
Medpace Holdings | 5,900 |
Bio-Techne | 3,050 |
Insulet | 3,000 |
Incyte | 2,524 |
ShockWave Medical | 1,468 |
CRL News
- 9 hours ago - Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP - Business Wire
- 10 days ago - Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally - Business Wire
- 16 days ago - Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing - Business Wire
- 20 days ago - Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call - Business Wire
- 21 days ago - Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology - Business Wire
- 23 days ago - Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics - Business Wire
- 4 weeks ago - Charles River to Perform Plasmid Production for Ship of Theseus - Business Wire
- 4 weeks ago - Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024 - Business Wire